Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook

Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook

The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the U.S. market, according to Jefferies, which cited data compiled…

Coca-Cola recalled 2,000 cases of drinks due to potential contamination

Coca-Cola recalled 2,000 cases of drinks due to potential contamination

Cans of Sprite and Fanta, beverages produced by the Coca-Cola Company, seen displayed in a supermarket. Alex Tai | Lightrocket | Getty Images The Food and Drug Administration disclosed the recall in a filing and said it began on Nov. 6. It encompasses 1,557 cases of 12-ounce cans of Sprite, 417 cases of Diet Coke,…

Moderna, Merck vaccine with Keytruda cuts risk of deadly skin cancer returning in half, data says

Moderna, Merck vaccine with Keytruda cuts risk of deadly skin cancer returning in half, data says

An exterior view of Moderna’s clinical manufacturing facility.  David L. Ryan | Boston Globe | Getty Images Moderna and Merck‘s experimental cancer vaccine, when used in combination with Merck’s blockbuster therapy Keytruda, reduced the risk of death or relapse in patients with the most deadly form of skin cancer by half after roughly three years,…

Covid inquiry: What is it investigating and how does it work?

Covid inquiry: What is it investigating and how does it work?

Image source, Getty Images By Jennifer Clarke BBC News Prime Minister Rishi Sunak robustly defended the Eat Out to Help Out Scheme he implemented as chancellor during the pandemic in his evidence to the Covid inquiry. Earlier, former Prime Minister Boris Johnson admitted he had underestimated the scale and the challenge of coronavirus. The inquiry’s…

If you can’t build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space

If you can’t build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space

Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly have the growing obesity drug market all to themselves. But given the potential size of this opportunity, which some have put at more than $100 billion by 2030 , other pharmaceuticals companies —…

Vertex shares pop after nonopioid painkiller posts positive midstage trial results

Vertex shares pop after nonopioid painkiller posts positive midstage trial results

A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019. Brian Snyder | Reuters Shares of Vertex Pharmaceuticals jumped Wednesday after the company’s painkiller, which is being tested as an alternative to opioids, significantly decreased pain in a midstage trial. Those positive results for diabetes patients suffering…